• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday

    6/11/24 8:53:07 AM ET
    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Restaurants
    Consumer Discretionary
    Packaged Foods
    Consumer Staples
    Get the next $DRI alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

    • JP Morgan slashed the price target for Nucor Corporation (NYSE:NUE) from $190 to $180. JP Morgan analyst Bill Peterson maintained a Neutral rating. Nucor shares fell 2.3% to close at $157.31 on Monday. See how other analysts view this stock.
    • Needham increased the price target for PAR Technology Corporation (NYSE:PAR) from $53 to $57. Needham analyst Mayank Tandon maintained a Buy rating. PAR Technology shares gained 6.1% to close at $45.57 on Monday. See how other analysts view this stock.
    • Wedbush slashed Darden Restaurants, Inc. (NYSE:DRI) price target from $181 to $170. Wedbush analyst Nick Setyan maintained an Outperform rating. Darden shares fell 0.6% to close at $147.68 on Monday. See how other analysts view this stock.
    • Baird raised the price target for First Solar, Inc. (NASDAQ:FSLR) from $246 to $344. Baird analyst Ben Kallo maintained an Outperform rating. First Solar shares rose 4.7% to close at $279.80 on Monday. See how other analysts view this stock.
    • HC Wainwright & Co. raised Oculis Holding AG (NASDAQ:OCS) price target from $28 to $30. HC Wainwright & Co. analyst Yi Chen maintained a Buy rating. Oculis Holding shares rose 0.3% to close at $12.00 on Monday. See how other analysts view this stock.
    • UBS boosted Targa Resources Corp. (NYSE:TRGP) price target from $116 to $147. UBS analyst Shneur Gershuni maintained a Buy rating. Targa Resources shares rose 1.6% to close at $119.91 on Monday. See how other analysts view this stock.
    • Benchmark boosted the price target for Freshpet, Inc. (NASDAQ:FRPT) from $125 to $150. Benchmark analyst John Lawrence maintained a Buy rating. Freshpet shares gained 2.3% to close at $129.93 on Monday. See how other analysts view this stock.
    • RBC Capital cut Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) price target from $424 to $421. RBC Capital analyst Brian Abrahams maintained a Sector Perform. Vertex Pharmaceuticals shares rose 0.1% to close at $483.28 on Monday. See how other analysts view this stock.
    • Susquehanna increased Western Digital Corporation (NASDAQ:WDC) price target from $80 to $88. Susquehanna analyst Medhi Hosseini maintained a Neutral rating. Western Digital shares rose 2.8% to close at $77.10 on Monday. See how other analysts view this stock.
    • Evercore ISI Group boosted Alphabet Inc. (NASDAQ:GOOGL) price target from $220 to $225. Evercore ISI Group analyst Mark Mahaney maintained an Outperform rating. Alphabet shares rose 0.4% to close at $175.01 on Monday. See how other analysts view this stock.

    Check This Out: Wall Street’s Most Accurate Analysts Give Their Take On 3 Financial Stocks With Over 7% Dividend Yields

    Get the next $DRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DRI
    $FRPT
    $FSLR
    $GOOGL

    CompanyDatePrice TargetRatingAnalyst
    Vertex Pharmaceuticals Incorporated
    $VRTX
    2/13/2026$540.00Perform → Outperform
    Oppenheimer
    Western Digital Corporation
    $WDC
    1/30/2026$200.00 → $325.00Buy
    TD Cowen
    First Solar Inc.
    $FSLR
    1/29/2026$263.00Outperform → Market Perform
    BMO Capital Markets
    Vertex Pharmaceuticals Incorporated
    $VRTX
    1/28/2026$606.00Overweight
    Barclays
    Nucor Corporation
    $NUE
    1/28/2026$183.00Buy → Neutral
    UBS
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    1/23/2026$333.00 → $346.00Buy
    Stifel
    Darden Restaurants Inc.
    $DRI
    1/23/2026Hold → Buy
    Melius
    More analyst ratings

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nucor Announces 212th Consecutive Cash Dividend and New Share Repurchase Program

    CHARLOTTE, N.C., Feb. 20, 2026 /PRNewswire/ -- The Board of Directors of Nucor Corporation (NYSE: NUE) declared the regular quarterly cash dividend of $0.56 per share on Nucor's common stock. This cash dividend is payable on May 11, 2026 to stockholders of record on March 31, 2026 and is Nucor's 212th consecutive quarterly cash dividend. In a separate action, Nucor's Board of Directors approved the repurchase of up to $4.00 billion of the Company's outstanding common stock.  This new authorization replaces the previously authorized $4.00 billion repurchase program (which was ter

    2/20/26 9:00:00 AM ET
    $NUE
    Steel/Iron Ore
    Industrials

    Nucor Announces Promotion of Jack Sullivan to Chief Financial Officer, Treasurer and Executive Vice President

    CHARLOTTE, N.C., Feb. 20, 2026 /PRNewswire/ -- Nucor Corporation (NYSE:NUE) announced today that John L. "Jack" Sullivan, Vice President, Treasurer and General Manager of Investor Relations, will be promoted to Chief Financial Officer, Treasurer and Executive Vice President effective March 1, 2026. He will succeed Steve Laxton, who was promoted to President and Chief Operating Officer effective January 1, 2026. Mr. Sullivan, 52, began his career with Nucor in 2022 as General Manager of Investor Relations and was promoted to his current role in 2025. Mr. Sullivan previously worke

    2/20/26 8:30:00 AM ET
    $NUE
    Steel/Iron Ore
    Industrials

    Targa Resources Corp. Announces Form 10-K Available

    HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE:TRGP) ("TRGP" or the "Company" or "Targa") has filed its Form 10-K with the Securities and Exchange Commission (SEC) for the year ended December 31, 2025. The report may be accessed at www.sec.gov. The report is also available in the Investors section of the Company's website at www.targaresources.com, or by going directly to https://www.targaresources.com/investors/financial-information/sec-filings. Hard copies of the report may be ordered free of charge by contacting the Company's investor relations department by email at [email protected], or by phone at (713) 584-1133. About Targa Resources Corp

    2/19/26 5:40:09 PM ET
    $TRGP
    Natural Gas Distribution
    Utilities

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Vertex Pharma upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Vertex Pharma from Perform to Outperform and set a new price target of $540.00

    2/13/26 7:53:31 AM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TD Cowen reiterated coverage on Western Digital with a new price target

    TD Cowen reiterated coverage of Western Digital with a rating of Buy and set a new price target of $325.00 from $200.00 previously

    1/30/26 6:45:51 AM ET
    $WDC
    Electronic Components
    Technology

    First Solar downgraded by BMO Capital Markets with a new price target

    BMO Capital Markets downgraded First Solar from Outperform to Market Perform and set a new price target of $263.00

    1/29/26 7:00:08 AM ET
    $FSLR
    Semiconductors
    Technology

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 30, 2025 - FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

    For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.  Journavx is the first dr

    1/30/25 5:46:14 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    FDA Approval for TRIKAFTA (COPACKAGED) issued to VERTEX PHARMS INC

    Submission status for VERTEX PHARMS INC's drug TRIKAFTA (COPACKAGED) (SUPPL-11) with active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR has changed to 'Approval' on 08/03/2023. Application Category: NDA, Application Number: 212273, Application Classification: Labeling

    8/4/23 4:36:00 AM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: President and CIO Porat Ruth covered exercise/tax liability with 47,141 units of Class C Capital Stock and was granted 94,715 units of Class C Capital Stock, increasing direct ownership by 20% to 862,377 units (SEC Form 4)

    4/A - Alphabet Inc. (0001652044) (Issuer)

    2/20/26 6:27:06 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Amendment: SVP, Chief Business Officer Schindler Philipp was granted 227,313 units of Class C Capital Stock and covered exercise/tax liability with 113,745 units of Class C Capital Stock, increasing direct ownership by 15% to 886,939 units (SEC Form 4)

    4/A - Alphabet Inc. (0001652044) (Issuer)

    2/20/26 5:56:10 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    President, Global Affairs, CLO Walker John Kent received a gift of 47,574 units of Class C Capital Stock and gifted 47,574 units of Class C Capital Stock, decreasing direct ownership by 67% to 23,507 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/20/26 5:34:53 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    SEC Filings

    View All

    SEC Form 8-K filed by Nucor Corporation

    8-K - NUCOR CORP (0000073309) (Filer)

    2/20/26 8:49:25 AM ET
    $NUE
    Steel/Iron Ore
    Industrials

    First Solar Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - FIRST SOLAR, INC. (0001274494) (Filer)

    2/19/26 4:03:11 PM ET
    $FSLR
    Semiconductors
    Technology

    SEC Form 10-K filed by Targa Resources Inc.

    10-K - Targa Resources Corp. (0001389170) (Filer)

    2/19/26 3:53:47 PM ET
    $TRGP
    Natural Gas Distribution
    Utilities

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Voss Capital, Lp bought $7,103,702 worth of shares (196,035 units at $36.24) (SEC Form 4)

    4 - PAR TECHNOLOGY CORP (0000708821) (Issuer)

    1/7/26 6:09:41 PM ET
    $PAR
    Office Equipment/Supplies/Services
    Miscellaneous

    Director George Walter N. bought $52,570 worth of shares (1,000 units at $52.57), increasing direct ownership by 2% to 46,527 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    9/18/25 6:19:40 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Director Fajemirokun-Beck Olufunlayo Olurinde bought $20,079 worth of shares (378 units at $53.12), increasing direct ownership by 4% to 9,615 units (SEC Form 4)

    4 - Freshpet, Inc. (0001611647) (Issuer)

    9/16/25 4:51:07 PM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Leadership Updates

    Live Leadership Updates

    View All

    Oculis Appoints Katie Kazem as Chief Legal Officer

    Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as external legal counsel to leading life sciences companiesChief Legal Officer (CLO) appointment enhances leadership capabilities to advance three highly differentiated late-stage assets toward near-term clinical and regulatory milestones ZUG, Switzerland, February 17, 2026 -- Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced the appointment of Katie Kazem as Chief Legal Officer, leading Oculis' le

    2/17/26 4:00:00 AM ET
    $OCS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Freshpet Strengthens Leadership Team with Strategic Appointments Across Finance and Supply Chain

    Appoints John O'Connor as Chief Financial Officer Appoints Ana Lopez as Senior Vice President Supply ChainCompany Reaffirms Full Year 2025 Outlook BEDMINSTER, N.J, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Freshpet, Inc. ("Freshpet" or the "Company") (NASDAQ:FRPT) today announced the appointment of John O'Connor as Chief Financial Officer, effective February 9, 2026, and Ana Lopez as Senior Vice President of Supply Chain, effective February 2, 2026. Mr. O'Connor succeeds Ivan Garcia, who has served as Interim Chief Financial Officer since October 2025 and will continue with the Company as Senior Vice President of Finance. Mr. O'Connor will report to Chief Executive Officer Billy Cyr, and Ms. Lope

    2/4/26 8:00:00 AM ET
    $FRPT
    Packaged Foods
    Consumer Staples

    Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs

    Experienced industry leader brings extensive expertise in leading breakthrough therapies through clinical development to marketing approval Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer ("CDO") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at Vertex Pharmaceuticals (NASDAQ:VRTX). She joins Satellos from Generation Bio (NASDAQ:G

    1/29/26 7:00:00 AM ET
    $GBIO
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Financials

    Live finance-specific insights

    View All

    Nucor Announces 212th Consecutive Cash Dividend and New Share Repurchase Program

    CHARLOTTE, N.C., Feb. 20, 2026 /PRNewswire/ -- The Board of Directors of Nucor Corporation (NYSE: NUE) declared the regular quarterly cash dividend of $0.56 per share on Nucor's common stock. This cash dividend is payable on May 11, 2026 to stockholders of record on March 31, 2026 and is Nucor's 212th consecutive quarterly cash dividend. In a separate action, Nucor's Board of Directors approved the repurchase of up to $4.00 billion of the Company's outstanding common stock.  This new authorization replaces the previously authorized $4.00 billion repurchase program (which was ter

    2/20/26 9:00:00 AM ET
    $NUE
    Steel/Iron Ore
    Industrials

    Targa Resources Corp. Announces Form 10-K Available

    HOUSTON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Targa Resources Corp. (NYSE:TRGP) ("TRGP" or the "Company" or "Targa") has filed its Form 10-K with the Securities and Exchange Commission (SEC) for the year ended December 31, 2025. The report may be accessed at www.sec.gov. The report is also available in the Investors section of the Company's website at www.targaresources.com, or by going directly to https://www.targaresources.com/investors/financial-information/sec-filings. Hard copies of the report may be ordered free of charge by contacting the Company's investor relations department by email at [email protected], or by phone at (713) 584-1133. About Targa Resources Corp

    2/19/26 5:40:09 PM ET
    $TRGP
    Natural Gas Distribution
    Utilities

    Darden Restaurants to Release Fiscal 2026 Third Quarter Results on March 19, 2026

    ORLANDO, Fla., Feb. 19, 2026 /PRNewswire/ -- Darden Restaurants, Inc. (NYSE:DRI) plans to release its fiscal 2026 third quarter financial results before the market opens on Thursday, March 19, 2026. The Company will host a conference call, led by Rick Cardenas, President and Chief Executive Officer, and Raj Vennam, Chief Financial Officer, to review third quarter results and conduct a question‑and‑answer session on Thursday, March 19, 2026, at 8:30 a.m. ET. The conference call will be webcast and can be accessed through the Company's Investor Relations website at investor.darden.com. Supplementary materials will be available on the website prior to the start of the conference call. A replay

    2/19/26 4:15:00 PM ET
    $DRI
    Restaurants
    Consumer Discretionary

    $DRI
    $FRPT
    $FSLR
    $GOOGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by First Solar Inc.

    SC 13D - FIRST SOLAR, INC. (0001274494) (Subject)

    12/10/24 1:11:10 PM ET
    $FSLR
    Semiconductors
    Technology

    SEC Form SC 13G filed by Oculis Holding AG

    SC 13G - Oculis Holding AG (0001953530) (Subject)

    12/9/24 9:43:55 PM ET
    $OCS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by PAR Technology Corporation

    SC 13G/A - PAR TECHNOLOGY CORP (0000708821) (Subject)

    11/14/24 1:28:29 PM ET
    $PAR
    Office Equipment/Supplies/Services
    Miscellaneous